Prostate Cancer - Results from #80

Association Between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer. December 31, 2019

Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy. December 31, 2019

Intensity modulated radiotherapy (IMRT) or conformational radiotherapy (3D-CRT) with conventional fractionation for prostate cancer: Is there any clinical difference? December 31, 2019

Opioid utilization is minimal after outpatient pediatric urologic surgery. December 30, 2019

Patient expectations of benefit from systemic treatments for metastatic prostate cancer. December 30, 2019

Role of combined radiation and androgen deprivation therapy in intermediate-risk prostate cancer : Statement from the DEGRO working group on prostate cancer. December 30, 2019

Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials). December 30, 2019

Associations Between Hospital Volume and Outcomes of Robot-Assisted Radical Prostatectomy. December 30, 2019

The cognitive fusion prostate biopsy using a smart phone in the diagnosis of prostate cancer. December 30, 2019

Hemi-Ablative Low-Dose-Rate Prostate Brachytherapy for Unilateral Localised Prostate Cancer. December 27, 2019

Characterization of a Prostate- and Prostate Cancer-Specific Circular RNA Encoded by the Androgen Receptor Gene. December 27, 2019

Patient-reported outcome measures after treatment for prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata). December 27, 2019

Liquid biopsy and prostate cancer. Current evidence applied to clinical practice. December 27, 2019

Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials. December 27, 2019

Diagnostic accuracy of prostate cancer antigen 3 (PCA3) prior to first prostate biopsy: A systematic review and meta-analysis. December 26, 2019

Should all prostate needle biopsy Gleason score 4 + 4 = 8 prostate cancers be high risk? Implications for shared decision-making and patient counselling. December 26, 2019

Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy. December 26, 2019

The role of adrenal derived androgens in castration resistant prostate cancer. December 26, 2019

Why the UK Should Consider Gene Expression Testing in Prostate Cancer. December 26, 2019

A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy. December 25, 2019

Page 5 of 1046